The role of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving Tacrolimus plus mycophenolate mofetil (MMF) immunosuppression.

被引：0

作者：

Kaufman, DB ^{[1
]}

Burke, G ^{[1
]}

Bruce, D ^{[1
]}

Sutherland, D ^{[1
]}

Johnson, C ^{[1
]}

Gaber, AO ^{[1
]}

Merion, R ^{[1
]}

Schweitzer, E ^{[1
]}

Marsh, C ^{[1
]}

Alfrey, E ^{[1
]}

Leone, J ^{[1
]}

Concepion, W ^{[1
]}

Stegall, M ^{[1
]}

Gores, P ^{[1
]}

Danovitch, G ^{[1
]}

Tolzman, D ^{[1
]}

Scotellaro, P ^{[1
]}

Salm, K ^{[1
]}

Keller, A ^{[1
]}

Fitzsimmons, WE ^{[1
]}

机构：

[1] Northwestern Univ, Chicago, IL 60611 USA

来源：

TRANSPLANTATION | 2000年 / 69卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

357

引用

页码：S206 / S206

页数：1

共 50 条

[1] Basilixamab induction verses no induction in simultaneous kidney pancreas (SPK) transplantation using mycophenolate/tacrolimus/prednisone (MMF/FK/PRED) maintenance immunosuppression.
Leone, JP
Taylor, RJ
[J]. TRANSPLANTATION, 2000, 69 (08) : S410 - S410
[2] Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil and steroids as maintenance immunosuppression.
Roth, D
Kuehnel, F
Angelis, M
Colona, J
Burke, G
Ciancio, G
Esquenazi, V
Miller, J
[J]. TRANSPLANTATION, 1999, 67 (09) : S602 - S602
[3] The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas-kidney recipients with previous transplants
Ciancio, G
Miller, J
Burke, GW
[J]. CLINICAL TRANSPLANTATION, 2001, 15 (02) : 142 - 145
[4] Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone
Lo, A
Stratta, RJ
Egidi, MF
Kizilisik, AT
Shokouh-Amiri, MH
Grewal, HP
Trofe, J
Alloway, RR
Gaber, AO
[J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1796 - 1798
[5] Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients
Ciancio, G
Burke, GW
Suzart, K
Roth, D
Kupin, W
Rosen, A
Olson, L
Esquenazi, V
Miller, J
[J]. TRANSPLANTATION, 2002, 73 (07) : 1100 - 1106
[6] Outcomes with De Novo Sirolimus/Mycophenolate Mofetil (MMF) Versus Tacrolimus/MMF in High-Risk Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
Centeno, A.
Duhart, B., Jr.
Krauss, A.
Patel, S.
Rao, V.
Eason, J.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 412 - 412
[7] Two-dose daclizumab induction treatment versus thymoglobuline in renal transplant patients receiving a mycophenolate mofetil based immunosuppression.
Ayache, RA
Lebranchu, Y
Lepogamp, P
Westeel, JF
Le Meur, Y
Etienne, I
De Ligny, BH
Toupance, O
Caillard, S
Goujon, JM
Bergougnoux, L
Miloradovich, T
Touchard, G
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 187 - 187
[8] Multivariate analysis of the impact of CMV in simultaneous pancreas-kidney (SPK) transplantation in the mycophenolate mofetil/tacrolimus era.
Kaufman, DB
Parker, M
Leventhal, J
Koffran, A
Abecassis, M
Fryer, J
Stuart, J
Stuart, FP
[J]. TRANSPLANTATION, 2000, 69 (08) : S271 - S271
[9] Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids
Glotz, Denis
Charpentier, Bernard
Abramovicz, Daniel
Lang, Philippe
Rostaing, Lionel
Rifle, Gerard
Vanrenterghem, Yves
Berthoux, Francois
Bourbigot, Bernard
Delahousse, Michel
Chalopin, Jean-Marc
Cassuto, Elisabeth
Lefrancois, Nicole
[J]. TRANSPLANTATION, 2010, 89 (12) : 1511 - 1517
[10] Corticosteroid minimization in pediatric renal transplant recipients under thymoglobulin, tacrolimus and mycophenolate mofetil immunosuppression.
Smith, LD
Somerville, KT
Holman, J
Sherbotie, J
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 647A - 647A

← 1 2 3 4 5 →